Medical director agreements in a med spa sale: continuity before closing

A med spa medical director agreement should be reviewed against actual services, state law, professional licenses, and the proposed ownership change. Buyers need evidence of genuine clinical oversight and a workable transition. A signed contract alone does not establish lawful operations, eliminate historical exposure, or ensure the director remains available after closing.

Why does the medical director agreement matter to a buyer?

The buyer is acquiring an operating business whose services depend on authorized professionals. If the clinical structure changes at closing, the business may lose access to services that support the earnings model. A director’s departure can therefore affect patient continuity, scheduling, staffing, and debt repayment at once.

The title medical director does not define a universal scope of responsibility. Ask what the physician actually does, which services and locations are covered, who examines patients, how delegation works, and who can make clinical decisions. Match each answer to current documents and operational evidence.

Clinical continuity is the planned ability to provide authorized care, supervision, and follow-up without a transaction-created gap. It is distinct from simply keeping the same brand or booking system. The director agreement is one part of that continuity plan, alongside staffing, ownership, records, protocols, and insurance.

Which legal rules should the review start with?

Begin with the state where care occurs and the licenses of the professionals involved. The Medical Board of California’s med-spa resource describes medical procedures and supervision in California. It should not be generalized into a rule for every state or every professional category.

Also review control over clinical judgment. The California board’s corporate-practice guidance identifies decisions reserved to licensed physicians. An administrative contract should not be assumed to authorize an investor to control those decisions. Ask counsel to assess the full set of ownership and management agreements, not just the director document.

Write a service-by-service legal review scope covering injectables, energy-based treatments, prescription products, and any wellness services. New services can introduce different requirements. A broad promise that a director covers all treatments is not proof that each treatment has the necessary examination, delegation, training, and supervision pathway.

What should the agreement and evidence file contain?

Collect the executed agreement, all amendments, license verification, insurance evidence, coverage arrangements, relevant policies, and records demonstrating assigned work. Identify the legal parties, effective dates, covered locations, services, compensation, duties, availability, and reporting relationships. Check that the documents reference the business as it currently operates.

This is a diligence organization tool, not a model medical-director contract. Counsel and clinical reviewers should tailor the required evidence. Avoid putting identifiable patient details into a general transaction folder just to prove that review activity occurred.

How do you test whether oversight exists in practice?

Ask staff to explain the real escalation process. Who handles a complication, a prescribing question, a new service, an unavailable provider, or a patient who needs follow-up? Compare that description with written policies and the director’s account. Inconsistent answers reveal a need for investigation, not automatic proof of wrongdoing.

Review how protocols are approved and updated, how staff competence is assessed, and how complaints or adverse events reach the responsible clinician. Determine whether coverage remains workable across locations and business hours. A schedule that relies on one unavailable person may not support the buyer’s operating model.

Do not prescribe a universal number of chart reviews, onsite visits, or supervision hours. Those details depend on state rules, professional duties, services, clinical risk, and the arrangement. The transaction team’s job is to secure qualified assessment and reliable evidence, not replace medical judgment with a generic acquisition checklist.

What happens if the agreement has expired or is missing?

Separate future coverage from historical conduct. Signing a new contract may address a prospective requirement but does not establish that past operations were compliant. Preserve records, involve healthcare counsel, and ask qualified reviewers to assess actual services, dates, professional roles, insurance, and potential reporting obligations.

Avoid backdating or creating records that imply work occurred when it did not. A truthful chronology is necessary for legal assessment and buyer disclosure. Determine whether the practice should change services or scheduling while remediation occurs; clinical decisions belong to appropriate professionals.

Price and timing consequences should follow the evidence. The parties may need additional review, a changed closing date, specific representations, an indemnity, or a revised operating model. Some findings cannot be cured through a price reduction because the buyer still needs lawful day-one operations.

How can a transaction end the director’s coverage?

Read assignment, change-of-control, termination, notice, and consent provisions. An asset purchase and an equity transfer can trigger different contractual consequences. Do not infer continuity from the fact that the practice name remains the same. The contracting party or professional entity may change even when patients see the same sign.

Speak with the director at an agreed stage. Confirm willingness, required compensation, services, locations, availability, and any concerns about the new owner’s expectations. A buyer should not rely on the seller’s assurance alone when a critical professional has not accepted the arrangement.

Coordinate coverage with professional-entity ownership and provider agreements. In a multi-entity structure, the administrative business may close while another required step remains incomplete. Tie closing conditions to the functioning service model rather than treating every signed document as an independent finish line.

How do insurance and privacy belong in this review?

Ask insurance advisors to identify the policies covering the director, treating professionals, and relevant entities. Review policy periods, exclusions, claims reporting, and whether a transaction or departure changes protection. Occurrence and claims-made policies can create different continuity questions; obtain advice on any needed tail or prior-acts arrangements.

The HHS Privacy Rule summary distinguishes permitted disclosures and applicable safeguards for covered entities. Have counsel determine the legal basis for any transaction access to protected information. An NDA or director title alone does not authorize unrestricted release of patient records to a buyer or advisor.

For product oversight, review sourcing procedures and responsibility for supplier approval. The full diligence guide addresses purchasing evidence alongside device, membership, and financial records. Keep clinical and commercial review coordinated while limiting each reviewer’s access to what is appropriate.

How should compensation and commercial expectations be discussed?

Clarify what the director’s compensation buys: defined professional duties, availability, administrative responsibilities, or other permitted work. Have counsel assess the arrangement against applicable rules rather than relying on a percentage seen in another practice. Commercial incentives should not override the professional judgment required for patient care.

Budget for realistic coverage under the buyer’s service plan. If the acquisition adds a location or extends hours, the old arrangement may not meet the new need. Agree how additional duties are approved and paid. A low historical fee is not evidence that equivalent post-closing oversight can be obtained at the same cost.

What should be completed before the parties close?

Create a dated coverage plan showing the responsible professional before, at, and after closing. Include backup availability, communication channels, staff training on changes, and how patients receive required information. If a replacement is needed, confirm that onboarding and approvals are complete before relying on that person in the operating budget.

1. Confirm current legal requirements with healthcare counsel.
2. Match the executed documents to services and entities.
3. Review evidence of actual clinical oversight.
4. Resolve termination, consent, coverage, and insurance issues.
5. Verify the post-closing arrangement before authorizing service continuity.

Use the seller hub and sale process guide to sequence this work early. A documented director transition helps buyers evaluate earnings continuity. It should never be presented as a substitute for independent legal or clinical review of the practice itself.

Educational analysis prepared with AI-assisted research for The Med Spa Broker. “Last reviewed” records the source and editorial check date; it does not imply review by an attorney, clinician, or independent appraiser. Read our editorial standards.